BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 34768955)

  • 1. Liquid Biopsy: A New Translational Diagnostic and Monitoring Tool for Musculoskeletal Tumors.
    Hadjimichael AC; Pergaris A; Kaspiris A; Foukas AF; Theocharis SE
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of liquid biopsy in bone and soft tissue sarcomas: Present and future.
    Li X; Seebacher NA; Hornicek FJ; Xiao T; Duan Z
    Cancer Lett; 2018 Dec; 439():66-77. PubMed ID: 30223067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors.
    Bunda S; Zuccato JA; Voisin MR; Wang JZ; Nassiri F; Patil V; Mansouri S; Zadeh G
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer.
    Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z
    Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free DNA in blood as a noninvasive insight into the sarcoma genome.
    Namløs HM; Boye K; Meza-Zepeda LA
    Mol Aspects Med; 2020 Apr; 72():100827. PubMed ID: 31703948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome-Based Liquid Biopsy Approaches in Bone and Soft Tissue Sarcomas: Review of the Literature, Prospectives, and Hopes for Clinical Application.
    Agnoletto C; Pignochino Y; Caruso C; Garofalo C
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA.
    Junqueira-Neto S; Batista IA; Costa JL; Melo SA
    Acta Cytol; 2019; 63(6):479-488. PubMed ID: 30783027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid Biopsy: Current Status and Future Perspectives.
    Mader S; Pantel K
    Oncol Res Treat; 2017; 40(7-8):404-408. PubMed ID: 28693023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of circulating biomarkers in liquid biopsy diagnostics.
    Yeo JC; Lim CT
    Biotechniques; 2018 Oct; 65(4):187-189. PubMed ID: 30284936
    [No Abstract]   [Full Text] [Related]  

  • 10. Liquid Biopsy as a Tool for Differentiation of Leiomyomas and Sarcomas of Corpus Uteri.
    Dvorská D; Škovierová H; Braný D; Halašová E; Danková Z
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring.
    Kamińska P; Buszka K; Zabel M; Nowicki M; Alix-Panabières C; Budna-Tukan J
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.
    Fici P
    Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer.
    Raza A; Khan AQ; Inchakalody VP; Mestiri S; Yoosuf ZSKM; Bedhiafi T; El-Ella DMA; Taib N; Hydrose S; Akbar S; Fernandes Q; Al-Zaidan L; Krishnankutty R; Merhi M; Uddin S; Dermime S
    J Exp Clin Cancer Res; 2022 Mar; 41(1):99. PubMed ID: 35292091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced liquid biopsy technologies for circulating biomarker detection.
    Soda N; Rehm BHA; Sonar P; Nguyen NT; Shiddiky MJA
    J Mater Chem B; 2019 Nov; 7(43):6670-6704. PubMed ID: 31646316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
    Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
    Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of circulating tumor cells and cell-free nucleic acids is an infrequent event in synovial sarcoma: liquid biopsy analysis of 15 patients diagnosed with synovial sarcoma.
    Mihály D; Nagy N; Papp G; Pápai Z; Sápi Z
    Diagn Pathol; 2018 Oct; 13(1):81. PubMed ID: 30326929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsy: current technology and clinical applications.
    Nikanjam M; Kato S; Kurzrock R
    J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biopsy in ovarian cancer.
    Giannopoulou L; Lianidou ES
    Adv Clin Chem; 2020; 97():13-71. PubMed ID: 32448432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Cancer Therapy: Liquid Biopsy.
    Marmé D
    Oncol Res Treat; 2017; 40(7-8):402-403. PubMed ID: 28728143
    [No Abstract]   [Full Text] [Related]  

  • 20. Liquid biopsy in breast cancer: A comprehensive review.
    Alimirzaie S; Bagherzadeh M; Akbari MR
    Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.